{"disease":{"id":"leptomeningeal-metastasis","name":"leptomeningeal metastasis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07386886","title":"Development of a Novel Graded Prognostic Assessment (BC-LGPA) Model for Breast Cancer Leptomeningeal Metastasis","phase":"","overall_status":"COMPLETED","enrollment_count":403,"lead_sponsor_name":"Jian Zhang,MD","has_results":false},{"nct_id":"NCT07239102","title":"Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT07005791","title":"AI-Based Ultrasound Prediction Model for Intracranial Pressure and Prognosis in Lung Cancer Patients With Leptomeningeal Metastasis: A Dual-Center Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":142,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT06441045","title":"Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":112,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT06705049","title":"Retrospective Study on Leptomeningeal Metastasis of Solid Tumors","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":107,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT04178343","title":"Tomotherapy for Leptomeningeal Metastases","phase":"NA","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT03257124","title":"Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMS","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT04148898","title":"Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Second Affiliated Hospital of Nanchang University","has_results":false},{"nct_id":"NCT06399926","title":"Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya Reservoir","phase":"","overall_status":"RECRUITING","enrollment_count":64,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT04778800","title":"A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT06643000","title":"Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT06376292","title":"A Prospective Single Arm Phase II Exploratory Study on the Combination of Whole Brain Radiotherapy, Thiotepa Intrathecal Injection and Systemic Treatment of Primary Diseases in the Treatment of Solid Tumor Leptomeningeal Metastasis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":58,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04233021","title":"Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Intergroupe Francophone de Cancerologie Thoracique","has_results":false},{"nct_id":"NCT03082144","title":"Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false},{"nct_id":"NCT07177950","title":"A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":51,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT05746754","title":"Proton Cranio-spinal Irradiation for Leptomeningeal Metastasis","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT06462222","title":"Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Guangzhou Medical University","has_results":false},{"nct_id":"NCT07348965","title":"Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis","phase":"NA","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"Guangzhou University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT04420598","title":"DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"MedSIR","has_results":true},{"nct_id":"NCT06282874","title":"Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":41,"lead_sponsor_name":"Guangdong Association of Clinical Trials","has_results":false},{"nct_id":"NCT07092202","title":"Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT05414123","title":"A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide","phase":"","overall_status":"TERMINATED","enrollment_count":40,"lead_sponsor_name":"Biocept, Inc.","has_results":false},{"nct_id":"NCT06230055","title":"Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":37,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06762080","title":"Intrathecal Combination of Programmed Death-1 (PD-1)/Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Bispecific Antibody and Pemetrexed for Leptomeningeal Metastasis","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Guangzhou Medical University","has_results":false},{"nct_id":"NCT06296745","title":"Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib.","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Guangzhou Medical University","has_results":false},{"nct_id":"NCT06809530","title":"Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":34,"lead_sponsor_name":"Guangzhou Medical University","has_results":false},{"nct_id":"NCT06809517","title":"Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal Metastasis","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":34,"lead_sponsor_name":"Guangzhou Medical University","has_results":false},{"nct_id":"NCT03507244","title":"Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false},{"nct_id":"NCT06058988","title":"Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT04833205","title":"Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Hui Bu","has_results":false},{"nct_id":"NCT07398599","title":"Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Second Affiliated Hospital of Nanchang University","has_results":false},{"nct_id":"NCT05146219","title":"Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"TYK Medicines, Inc","has_results":false},{"nct_id":"NCT07263425","title":"Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Trastuzumab in Breast Cancer With Leptomeningeal Metastasis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":26,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT07098806","title":"Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Plus Therapeutics","has_results":false},{"nct_id":"NCT05805631","title":"Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":23,"lead_sponsor_name":"Taipei Veterans General Hospital, Taiwan","has_results":false},{"nct_id":"NCT06543992","title":"Efficacy and Safety of Intrathecal Administration of Thiotepa in Combination With Methotrexate in Breast Cancer With Leptomeningeal Metastasis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":22,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT07199413","title":"Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy: A Phase I Pilot Safety and Feasibility Study for Solid Tumor Patients With CNS Metastases","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false},{"nct_id":"NCT06984523","title":"Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"NYU Langone Health","has_results":false},{"nct_id":"NCT04425681","title":"Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Second Affiliated Hospital of Nanchang University","has_results":false},{"nct_id":"NCT05385185","title":"Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Hebei Medical University","has_results":false},{"nct_id":"NCT06663306","title":"Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":19,"lead_sponsor_name":"Shanghai Chest Hospital","has_results":false},{"nct_id":"NCT05034497","title":"Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Plus Therapeutics","has_results":false},{"nct_id":"NCT02948751","title":"Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Columbia University","has_results":true},{"nct_id":"NCT04729348","title":"Pembrolizumab And Lenvatinib In Leptomeningeal Metastases","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT05257967","title":"CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"British Columbia Cancer Agency","has_results":false},{"nct_id":"NCT04315246","title":"177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma)","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Y-mAbs Therapeutics","has_results":false}],"total":46},"guidelines":[],"source":"Drug Landscape verified database"}